Prime Medicine, a biotech whose wild ambitions for a powerful gene editing technology sank as the biotech market slumped, announced Monday it is replacing its CEO, laying off 25% of its staff, and scrapping its lead program.
https://www.statnews.com/2025/05/19/gene-editing-biotech-company-prime-medicine-announces-layoffs-ceo-departure/